A Phase 1 clinical trial at Cleveland Clinic demonstrated that a single infusion of the CRISPR-Cas9 gene-editing therapy, CTX310, led to substantial and lasting reductions in LDL cholesterol and triglycerides in patients with lipid disorders. After one year, the highest dose res…
Recent discussions around gene therapy have shed light on its potential to treat previously incurable genetic disorders. Notably, the case of Baby KJ, who received a personalized…
Trey McGowan, a 13-year-old diagnosed with glycogen storage disease Type 1a, relies on raw cornstarch to maintain stable blood sugar levels. His condition requires precise meal ti…
The experimental gene-editing drug VERVE-102, developed by Eli Lilly, has demonstrated the potential to reduce LDL cholesterol levels by up to 62% in early trials. This therapy ai…
A recent clinical trial led by researchers at the Cleveland Clinic has demonstrated that a one-time CRISPR treatment, known as CTX310, can significantly reduce levels of 'bad' cho…
A recent pilot study published in The New England Journal of Medicine reveals that a single gene-editing treatment using CRISPR technology can reduce cholesterol levels by approxi…
A recent study published in the New England Journal of Medicine highlights a promising CRISPR-based gene-editing therapy that may serve as a one-time treatment for individuals wit…
The FDA has granted accelerated approval for Genglycos, the first-ever therapy for patients aged 8 and older with glycogen storage disease type Ia (GSDIa). This gene therapy aims…
OptiPrime is a newly developed machine learning model that predicts the efficiency of prime editing in genomic DNA. By incorporating mechanistic insights into its design, OptiPrim…
A recent study involving over one million participants has identified a rare gene variant in FNIP1 that is associated with a significantly reduced risk of diabetes and heart disea…
Researchers are making significant strides in epigenetic editing, a technique that modifies chemical tags on DNA to influence gene expression without altering the genetic code its…
China's Ministry of Commerce and Ministry of Science and Technology has proposed export restrictions on 40 critical technologies, including artificial intelligence, semiconductors…
The James Bond franchise has long been known for its quirky and unconventional villains. This article delves into some of the most unusual antagonists from the series, highlightin…
CRISPR Therapeutics has seen its stock price decline over the past year, trading significantly below Wall Street's price targets. Analysts predict potential gains, with one projec…